Educational information, not medical advice — ask your doctor or midwife.
Track Grifola frondosa D-Fraction with reminders and record whether it helped, in the app.
D-Fraction is the most studied bioactive extract isolated from Maitake mushroom (Grifola frondosa), a prized edible and medicinal fungus native to northeastern Japan and parts of North America. Unlike whole Maitake powder, D-Fraction is a highly purified, standardized beta-glucan fraction — meaning it delivers a concentrated dose of the compound believed to drive the mushroom's most powerful health effects. It has been studied extensively in Japan since the 1980s and gained attention in the West as a natural immune-modulating and metabolic agent.
D-Fraction works primarily by activating and amplifying your immune system's frontline defenders — natural killer (NK) cells, macrophages, and T-cells — without causing the immune system to overreact. It does this by binding to specific receptors on immune cells, essentially waking them up and putting them on alert. Separately, Maitake compounds appear to support healthy blood sugar by improving how cells respond to insulin and slowing the absorption of glucose after meals.
Liquid D-Fraction drops (typically standardized to 0.5–1 mg of beta-glucan per drop) are the most studied clinical form and are considered the most bioavailable because they are absorbed in part through oral mucous membranes. Capsules and tablets containing standardized D-Fraction extract are widely available and convenient. Whole dried Maitake powder is nutritious but delivers far less concentrated beta-glucan and is not equivalent to the extract for clinical purposes.
Maitake mushroom has been used in Japanese folk medicine and cuisine for centuries, valued so highly that people reportedly danced with joy upon finding it in the wild — which is where the name 'Maitake' (dancing mushroom) originates. Japanese researcher Dr. Hiroaki Nanba isolated and characterized D-Fraction in the 1980s, sparking decades of research into its immune and anti-cancer properties. It became one of the first mushroom extracts to receive serious clinical study in oncology settings in Japan and later the United States.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.